HP
HealthInvest Partners Portfolio holdings
AUM $234M
1-Year Return
10.88%
This Quarter Return
-3.08%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$214M
AUM Growth
+$1.1M
(+0.52%)
Cap. Flow
-$281K
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
77.57%
Holding
21
New
7
Increased
5
Reduced
6
Closed
3
Top Buys
| 1 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
+$13.5M |
| 2 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$13.4M |
| 3 |
Merck
MRK
|
+$13.3M |
| 4 |
Bausch Health
BHC
|
+$9.73M |
| 5 |
FEIC
FEI COMPANY
FEIC
|
+$5.42M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$23.2M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$15.3M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$14.9M |
| 4 |
GNC
GNC Holdings, Inc.
GNC
|
+$7.44M |
| 5 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$6.86M |
Sector Composition
| 1 | Healthcare | 65.85% |
| 2 | Industrials | 8.73% |
| 3 | Financials | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Anika Therapeutics
ANIK
$125M
| $21.9M | 10.27% |
490,331
+111,586
| +29% | +$4.99M |
|
|
FEIC
2
DELISTED
FEI COMPANY
FEIC
| $21.3M | 9.99% |
239,609
+60,846
| +34% | +$5.42M |
|
|
LPNT
3
DELISTED
LifePoint Health, Inc.
LPNT
| $19M | 8.9% |
274,430
-99,000
| -27% | -$6.86M |
|
|
GNC
4
DELISTED
GNC Holdings, Inc.
GNC
| $18.6M | 8.73% |
586,955
-234,235
| -29% | -$7.44M |
|
|
AMAG
5
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $17.3M | 8.11% |
740,585
+220,585
| +42% | +$5.16M |
|
6
Supernus Pharmaceuticals
SUPN
$2.45B
| $13.8M | 6.45% |
903,533
-147,744
| -14% | -$2.25M |
|
7
Charles River Laboratories
CRL
$7.48B
| $13.5M | 6.34% |
178,307
-4,400
| -2% | -$334K |
|
|
TARO
8
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $13.5M | 6.31% |
+94,005
| New | +$13.5M |
|
|
SYNH
9
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $13.4M | 6.26% |
+324,270
| New | +$13.4M |
|
|
10
Merck
MRK
$202B
| $13.3M | 6.23% |
+263,467
| New | +$13.3M |
|
11
Elevance Health
ELV
$69.5B
| $13.1M | 6.11% |
93,900
-11,800
| -11% | -$1.64M |
|
|
GTS
12
DELISTED
Triple-S Management Corporation
GTS
| $12.5M | 5.86% |
529,575
-108,388
| -17% | -$2.56M |
|
|
13
Bausch Health
BHC
$2.53B
| $9.73M | 4.56% |
+370,000
| New | +$9.73M |
|
|
SSRG
14
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $3.12M | 1.46% |
316,427
+18,000
| +6% | +$177K |
|
15
OraSure Technologies
OSUR
$235M
| $2.93M | 1.37% |
+405,771
| New | +$2.93M |
|
16
Assertio
ASRT
$77.6M
| $2.79M | 1.3% |
+50,000
| New | +$2.79M |
|
|
SCLN
17
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $2.6M | 1.22% |
+236,288
| New | +$2.6M |
|
18
ImmuCell
ICCC
$50.7M
| $1.15M | 0.54% |
168,323
+43,031
| +34% | +$295K |
|
|
VAR
19
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-209,830
| Closed | -$14.9M |
|
|
20
Gilead Sciences
GILD
$138B
| – | – |
-229,300
| Closed | -$23.2M |
|
|
MGLN
21
DELISTED
Magellan Health Services, Inc.
MGLN
| – | – |
-248,934
| Closed | -$15.3M |
|